Novartis cuts CCO title as international chief Marie-France

Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial offic | Just as Novartis’ C-suite appeared to have stabilized amid a major overhaul of the company, the Swiss pharma is losing its international markets leader and getting rid of its chief commercial officer title.

Novartis AG Layoffs Announced: More Cuts May Be Looming

From the Heart

Novartis is losing its chief commercial officer - STAT

424B4

Tschudin Facebook, Instagram & Twitter on PeekYou

Novartis' Top Japan Executives Quit over Cancer Drug Scandal

The 47th Annual Meeting of the European Society for Blood and

Document

Novartis to eliminate up to 8000 jobs under cost-cutting plan

UPDATED: Novartis CEO Vas Narasimhan restructures the pharma giant, cutting costs $1B+, ousting top execs and signaling layoffs ahead - ECHEMI